Effect of reporting bias in the analysis of spontaneous reporting data.

@article{Ghosh2015EffectOR,
  title={Effect of reporting bias in the analysis of spontaneous reporting data.},
  author={Palash Ghosh and Anup Dewanji},
  journal={Pharmaceutical statistics},
  year={2015},
  volume={14 1},
  pages={
          20-5
        }
}
It is well-known that a spontaneous reporting system suffers from significant under-reporting of adverse drug reactions from the source population. The existing methods do not adjust for such under-reporting for the calculation of measures of association between a drug and the adverse drug reaction under study. Often there is direct and/or indirect information on the reporting probabilities. This work incorporates the reporting probabilities into existing methodologies, specifically to Bayesian… 

Tables from this paper

Estimation of the Under-Reporting of Suspected Serious Adverse Drug Reactions in Japan Using An Interrupted Time Series Analysis.
TLDR
The existence of sADR under-reporting in spontaneous reports in Japan quantitatively was demonstrated and it was suggested that information on sADRs was reported appropriately according to their level of severity.
Bias in Spontaneous Reporting of Adverse Drug Reactions in Japan
TLDR
Healthcare professionals may be more likely to report serious ADRs than to report non-serious ADRs, but the effect of event prominence on reporting trends is still unclear and Pharmacovigilance specialists should be cautious when comparing data between different time periods or different countries.
Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source.
TLDR
Signal detection using data mining is described, considering traditional methods and the latest knowledge, and their limitations, including methods that consider the patient background and those that identify drug-drug interactions.
Sample size of the reference sample in a case‐augmented study
TLDR
This work addresses the minimum sample size calculation and discusses related issues in case‐augmented study and the required minimum size of the reference sample.
Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
TLDR
Findings support the similarity in the signals of disproportionate reporting between cancer supportive care originator biologics and biosimilars, except for Fulphila ® .
Safety of Perflutren Ultrasound Contrast Agents: A Disproportionality Analysis of the US FAERS Database
TLDR
The combined signal detection/evaluation analysis did not identify SDRs of novel adverse events or major cardiovascular events associated with perflutren ultrasound contrast agents, and the negative results for major cardiovascular Events extend previous signal evaluation exercises supporting the relative cardiovascular safety of these agents.
Comparisons of adverse event reporting for colistin versus polymyxin B using the US Food and Drug Administration Adverse Event Reporting System (FAERS)
TLDR
This study showed higher reporting rates of serious AEs and AKD for colistin than polymyxin B, but no difference in death, which supports future research with stronger study design and larger sample size for the safety comparison between colistIn and polymyXin B.
Real-world burden of comorbidities in US patients with psoriatic arthritis
TLDR
Patients with psoriatic arthritis had notably higher incidence rates of uveitis, fibromyalgia, osteoporosis, Crohn’s disease and non-alcoholic liver disease than patients with psoriasis, and the observed high cardiometabolic comorbidity rates align with those reported in the literature.
Workload of pharmacists and the performance of pharmacy services
TLDR
Reduced pharmacist workload was associated with re-allocation of pharmacy time to provide prescription suggestions and, more recently, decrease dispensing errors.
Real‐world burden of comorbidities in US patients with psoriasis
...
1
2
...

References

SHOWING 1-10 OF 10 REFERENCES
On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under-reporting on odds ratios
TLDR
It is shown that certain under-reporting problems play no role in assessing ADRs from SRSs: the results from the analyses turn out to be biased by some specific under- reporting problems, but not by others.
Analysis of spontaneous adverse drug reaction (ADR) reports using supplementary information.
TLDR
The existing work to analyze the SR database and their drawbacks are discussed and methodologies to tackle these drawbacks are suggested by defining a source population and considering the problem of under-reporting, with the help of supplementary data.
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
TLDR
The objective of this study is to examine the level of concordance of the various estimates to the measure used by the WHO Collaborating Centre for International ADR monitoring, the information component (IC), when applied to the dataset of the Netherlands Pharmacovigilance Foundation Lareb.
Quantitative signal detection using spontaneous ADR reporting
TLDR
The role of Bayesian shrinkage in screening spontaneous reports, the importance of changes over time in screening the properties of the measures and some suggestions as to where emerging research is likely to lead are given.
Evaluation of statistical association measures for the automatic signal generation in pharmacovigilance
TLDR
Evaluating association measures on simulated datasets obtained with SRS modeling to identify which measures appeared to be the most relevant for pharmacovigilance found them to be.
Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System
TLDR
Here, a baseline or null hypothesis expected frequency is constructed for each cell, and screening criteria for ranking the cell deviations of observed from expected count are suggested and compared.
A Bayesian neural network method for adverse drug reaction signal generation
TLDR
The BCPNN will be an extremely useful adjunct to the expert assessment of very large numbers of spontaneously reported ADRs, and can be used in the detection of significant signals from the data set of the WHO Programme on International Drug Monitoring.
Prescription-event monitoring--recent progress and future horizons.
  • R. Mann
  • Medicine
    British journal of clinical pharmacology
  • 1998
TLDR
The backbone of the post-marketing techniques that have been developed to survey the use of newly marketed drugs in large populations is provided by the hypothesis-generating methods, including spontaneous adverse drug reaction (ADR) reporting and prescription-event monitoring (PEM).
Pharmaceutical Use and Expenditure for Cardiovascular Disease and Stroke
This study presents the results of a joint analysis of patterns of consumption, expenditure, and unit expenditure for a core set of drugs aimed at preventing and treating cardiovascular disease. The
NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics.
TLDR
Use of NSAIDs in elderly patients taking diuretics is associated with a 2-fold increased risk of hospitalization for CHF, especially in those with existing serious CHF.